WASHINGTON (Reuters) - U.S. drug reviewers recommended that regulators further study the effects of atypical antipsychotic medicines in children, a report released on Friday said. Food and Drug Administration staff said a study of the medical l... fdastaffurgeantipsychoticreviewkids
To comment or read full article login. No account? Register free.